These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7103275)

  • 1. Digoxin, propranolol, and atrioventricular reentrant tachycardia in the Wolff-Parkinson-White syndrome.
    Hung JS; Kou HC; Wu D
    Ann Intern Med; 1982 Aug; 97(2):175-82. PubMed ID: 7103275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
    Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The electrophysiologic effects of intravenous propranolol in the Wolff-Parkinson-White syndrome.
    Barrett PA; Jordan JL; Mandel WJ; Yamaguchi I; Laks MM
    Am Heart J; 1979 Aug; 98(2):213-24. PubMed ID: 453024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrioventricular reciprocal rhythm and chronic reciprocating tachycardia in a newborn infant with concealed Wolff-Parkinson-White syndrome.
    Sung RJ; Ferrer P; Garcia OL; Castellanos A; Gelband H
    Br Heart J; 1977 Jul; 39(7):810-4. PubMed ID: 884032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acebutolol on paroxysmal atrioventricular reentrant tachycardia in patients with manifest or concealed accessory pathways.
    Kou HC; Yeh SJ; Lin FC; Hung JS; Wu D
    Chest; 1983 Jan; 83(1):92-7. PubMed ID: 6848337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker therapy for the Wolff-Parkinson-White syndrome.
    Prystowsky EN; Greer S; Packer DL; Thompson KA; German LD
    Am J Cardiol; 1987 Aug; 60(6):46D-50D. PubMed ID: 2888300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
    Dolla E; Levy S; Cointe R; Moyal C; Bru P; Rossi P; Gérard R
    Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of the delta wave in the Wolff-Parkinson-White syndrome. A misleading indicator of therapeutic effectiveness.
    Jordan J; Yamaguchi I; Mandel WJ
    Chest; 1978 Feb; 73(2):215-8. PubMed ID: 620586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
    Feld GK; Nademanee K; Weiss J; Stevenson W; Singh BN
    J Am Coll Cardiol; 1984 May; 3(5):1298-307. PubMed ID: 6707383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiologic effects of intravenous digoxin in infants and children with Wolff-Parkinson-White syndrome].
    Fujiseki Y; Hidetoshi F; Umemura N; Nishijima S; Hattori M; Shimada M; Sugiyama T; Nishikawa R; Kiyosawa N; Mizuta R
    Kokyu To Junkan; 1989 Aug; 37(8):891-4. PubMed ID: 2616919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
    Kou HC; Hung JS; Lee YS; Wu D
    Circulation; 1982 Aug; 66(2):454-62. PubMed ID: 6807567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
    Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiological effects of the combined administration of digoxin and propranolol in man].
    Morena H; Chaltiel MG; Denis B; Gavend M; Martin-Noël P
    Arch Mal Coeur Vaiss; 1978 Oct; 71(10):1143-53. PubMed ID: 104687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.